A Pharmacokinetic Drug Interaction Between Fimasartan and Linagliptin in Healthy Volunteers

OBJECTIVE: Fimasartan, an angiotensin II type 1 receptor blocker, and linagliptin, a dipeptidyl-peptidase-4 inhibitor, are frequently coadministered to treat patients with hypertension and diabetes, respectively. This study sought to evaluate the pharmacokinetic interactions between fimasartan and l...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Drug Des Devel Ther
Main Authors: Kang, Woo Youl, Lee, Hae Won, Gwon, Mi-Ri, Cho, Seungil, Shim, Wang-Seob, Lee, Kyung-Tae, Yang, Dong Heon, Seong, Sook Jin, Yoon, Young-Ran
Formato: Artigo
Idioma:Inglês
Publicado em: Dove 2020
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7266304/
https://ncbi.nlm.nih.gov/pubmed/32546973
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S248205
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados